NFKB1 and gastric cancer: We found that trastuzumab treatment induces p53 upregulated modulator of apoptosis (PUMA) expression in GC cells, through the NF‐κB pathway following AKT inhibition and glycogen synthase kinase 3β (GSK3β) activation.